Azvudine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

PneumoniaChronic HepatitisRenal Insufficiency

155 competitors in Pneumonia

#DrugCompanyPhaseTrials

1

Azvudine

HHenan Genuine Biotech Co., Ltd.

Phase 3

12

Plaquenil

Jazz Pharmaceuticals

Preclinical

13

Innohep

Jazz Pharmaceuticals

Preclinical

14

Jakafi

Incyte

Preclinical

15

Primaquine

Sanofi

Preclinical

16

Acanya

Pfizer

Preclinical

17

Prevacid

Takeda

Preclinical

18

Avlosulfon

AAlmirall, S.A.

Preclinical

49

Zantac 150

CChattem

Preclinical

210

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

2Show 36 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

COVID-199 trials

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

Completed·TThe First Affiliated Hospital of Zhengzhou University··NCT06349655·32,864 enrolled

Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)

Completed·HHRH Pharmaceuticals Limited·Phase 3·NCT04668235·180 enrolled

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

Unknown status·SSoutheast University, China·N/A·NCT05642910·540 enrolled

Show 6 more trials

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

Recruiting·PPeking Union Medical College Hospital·Phase 2/3·NCT05689034·1,096 enrolled

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

Unknown status·Shanghai Henlius Biotech·Phase 2/3·NCT05633433·1,550 enrolled

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

Unknown status·FFifth Affiliated Hospital, Sun Yat-Sen University··NCT06006611·4,201 enrolled

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

Completed·HHRH Pharmaceuticals Limited·Phase 3·NCT05033145·312 enrolled

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

Unknown status·SShandong Provincial Hospital·Phase 4·NCT05697055·410 enrolled

Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China

Unknown status·Shanghai Henlius Biotech·Phase 2·NCT05682599·300 enrolled

Interaction1 trial

A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Aluvia

Completed·HHenan Genuine Biotech Co., Ltd.·Phase 1·NCT07002242·15 enrolled

Adult Subject1 trial

A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects

Completed·HHenan Genuine Biotech Co., Ltd.·Phase 1·NCT06991634·24 enrolled

Clinical Trial1 trial

[14C] Mass Balance Clinical Trial of Azvudine in Healthy Male Subjects

Completed·HHenan Genuine Biotech Co., Ltd.·Phase 1·NCT07002281·6 enrolled

Renal insufficiency1 trial

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects

Recruiting·HHenan Genuine Biotech Co., Ltd.·Phase 1·NCT07001436·40 enrolled

3 more indications

Chronic Hepatitis1 trial

A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B

Recruiting·ZZhigang Ren·Phase 3·NCT07307586·120 enrolled

Efficacy and Safety1 trial

Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients

Unknown status·Shanghai Henlius Biotech··NCT05675748·400 enrolled

Pneumonia1 trial

An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia

Unknown status·QQianfoshan Hospital··NCT05621993·500 enrolled

Details

Drug Info

Related News